《半日总结》恒指升36点 小米挫半成 京东系受捧
市场观望美联储议息，美股昨(27日)个别发展，港股早市窄幅争持。恒指高开50点，早段曾跌54点一度低见28,887点，其後曾升126点一度高见29,067点，半日升36点或0.13%，报28,978点；国指升1点或0.01%，报10,984点；恒生科技指数跌9点或0.1%，报8,507点。大市半日成交总额699.76亿元，沪、深港通南下交易半日录得净流入金额分别为1.62亿及10.85亿元人民币。
京东物流进行上市聆讯消息带动京东系股份，京东(09618.HK)升3%报306.8元，京东健康(06618.HK)升6%报127元。小米(01810.HK)手机首季於印度市占率下跌，早市股价跌5.1%报24.95元。其他科技股方面，阿里巴巴(09988.HK)升1.9%报230.8元，腾讯(00700.HK)升0.3%报627元，美团(03690.HK)跌1.1%报309.6元，百度(09888.HK)升0.3%报211.8元，哔哩哔哩(09626.HK)升2.6%报956元，快手(01024.HK)跌0.2%报273.4元。
此外，恒腾(00136.HK)、阿里健康(00241.HK)、阅文(00772.HK)、美图(01357.HK)、平安好医生(01833.HK)、众安在线(06060.HK)、金蝶(00268.HK)及心动(02400.HK)各跌2.2%至2.7%，新东方在线(01797.HK)跌4.5%。携程(09961.HK)则升2.1%。手机相关股信利(00732.HK)跌2.2%，晶片设备股ASM太平洋(00522.HK)升3.4%。电讯股方面，中电信(00728.HK)发行A股申请获中证监受理，股价升3%报2.77元。中移动(00941.HK)平收报52.05元。
医药股方面，白云山(00874.HK)首季多赚38%，股价升6.7%。信达生物(01801.HK)及复星医药(02196.HK)各升4.5%及6.9%，药明生物(02269.HK)反弹3.1%，中生制药(01177.HK)则跌2.6%。
内需股方面，百胜中国(09987.HK)首季纯利升2.7倍，早市股价升5.8%。万洲(00288.HK)附属双汇发展首季少赚1.6%，股价仍升3.5%。阿里影业(01060.HK)跌2.6%。汽车股吉利(00175.HK)遭瑞银唱淡，股价跌3.7%。东风(00489.HK)跌2.1%。体育股安踏(02020.HK)升3.3%。
金属及资源股受压，江铜(00358.HK)首季纯利8.59亿元人币升4.36倍，股价跌4.4%。五矿资源(01208.HK)、中铝(02600.HK)、洛钼(03993.HK)、紫金(02899.HK)及灵宝黄金(03330.HK)各跌3.3%至4.2%。中国黄金国际(02099.HK)跌2.7%。航运股东方海外(00316.HK)据报遭股东折让逾11%配股套现8.4亿元，东方海外股价跌7.5%收125.4元。同业中远海控(01919.HK)亦回吐3.6%。
金融股方面，汇控(00005.HK)绩後获多间大行上调目标价，股价升2%报46.9元，港交所(00388.HK)升0.9%报494.4元，友邦(01299.HK)跌0.6%报99元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
